JLCYX
Price
$76.25
Change
+$0.13 (+0.17%)
Updated
Oct 17 closing price
Net Assets
6.23B
VSTSX
Price
$313.67
Change
+$1.37 (+0.44%)
Updated
Oct 17 closing price
Net Assets
2.02T
Interact to see
Advertisement

JLCYX vs VSTSX

Header iconJLCYX vs VSTSX Comparison
Open Charts JLCYX vs VSTSXBanner chart's image
JHancock Fundamental Large Cap Core R2
Price$76.25
Change+$0.13 (+0.17%)
VolumeN/A
Net Assets6.23B
Vanguard Total Stock Mkt Idx Instl Sel
Price$313.67
Change+$1.37 (+0.44%)
VolumeN/A
Net Assets2.02T
JLCYX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
JLCYX vs. VSTSX commentary
Oct 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JLCYX is a Hold and VSTSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.02T vs. JLCYX (6.23B). VSTSX pays higher dividends than JLCYX: VSTSX (1.15) vs JLCYX (0.15). JLCYX was incepted earlier than VSTSX: JLCYX (14 years) vs VSTSX (9 years). JLCYX (1.17) is less costly to investors than VSTSX (0.01). JLCYX is a more actively managed with annual turnover of: 19.00 vs. VSTSX (2.00). JLCYX has a lower initial minimum investment than VSTSX: JLCYX (0) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 13.82 vs. JLCYX (-2.21). VSTSX return over 5 years is better than : 85.01 vs. JLCYX (34.44).
JLCYXVSTSXJLCYX / VSTSX
Total Expense Ratio1.160.0111,600%
Annual Report Gross Expense Ratio1.170.0111,700%
Fund Existence14 years9 years-
Gain YTD7.09313.02954%
Front LoadN/AN/A-
Min. Initial Investment05000000000-
Min. Initial Investment IRAN/AN/A-
Net Assets6.23B2.02T0%
Annual Yield % from dividends0.151.1513%
Returns for 1 year-2.2113.82-16%
Returns for 3 years35.8776.1647%
Returns for 5 years34.4485.0141%
Returns for 10 years79.33N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INDP3.700.27
+7.87%
Indaptus Therapeutics Inc
APPN28.150.36
+1.30%
Appian Corp
IONS73.090.02
+0.03%
Ionis Pharmaceuticals
LGO1.29-0.03
-2.27%
Largo
FDMT9.84-0.25
-2.48%
4D Molecular Therapeutics